Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 2Phase NA 1Phase 1/2 1

Status

Completed 4Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 6Gastrointestinal 1

Conditions

Breast Neoplasms 4Risk Reduction Behavior 1Pancreatic Neoplasms 1Hot Flashes 1Focus of Study is Healthy Women at Risk for Breast Cancer 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
OTHER × bazedoxifene × Clear all
NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

University of Kansas Medical Center

Phase 2 Active not recruiting
120 enrolled
Breast

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior

NCT04821375 2025-10-29

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

University of Kansas Medical Center

Phase EARLY_PHASE1 Completed
16 enrolled
Breast

Breast Neoplasms

NCT02694809 2025-01-28

The PROMISE Study: Duavee in Women With DCIS

Northwestern University

Phase 2 Completed
142 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT02448771 2022-10-24

A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer

Dana-Farber Cancer Institute

Phase 1/2 Completed
36 enrolled 28 charts
Breast

Breast Neoplasms

NCT02729701 2022-03-09

Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation

University of Kansas Medical Center

Phase 2 Completed
28 enrolled 9 charts
Breast

Breast Neoplasms

NCT04812808 2022-02-25

BAZE

Hôpital Fribourgeois

Phase NA Unknown
10 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04379024 2021-10-29

Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms

University of Kansas Medical Center

Phase EARLY_PHASE1 Terminated
11 enrolled
Breast

Focus of Study is Healthy Women at Risk for Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡